By Scott Cullen MD – Health systems are facing new and rapidly evolving challenges and leaders are being pushed to innovate at the same pace as a result. Meeting the immediate needs of the system may seem paramount, but healthcare leaders must take a long-term, strategic approach to transformation to reap the full benefits.
Read More
By Ritesh Ramesh – Overcoding may net higher reimbursements for healthcare organizations, however the ramifications of getting caught far outweigh the revenue boost – and the likelihood of that happening are high as CMS continues its quest to ferret out fraud and abuse and recoup improper reimbursements.
By Greg Davis – Telehealth is on the rise, and it’s not linear – it’s exponential. Internet downtime can severely damage your reputation, operations, and your ability to stay competitive with other practices and clinics, even if your services may be of a better grade.
By Candida Valois – The nation’s cybersecurity strategy underscores the imperative for healthcare organizations to make bold changes and significant improvements in health data protection. A study by JAMA found that from 2016 to 2021, cyberattacks on healthcare organizations more than doubled.
By Troy Ament – The exponential growth of IoT and medical devices has increased the attack surface of these systems. Ransomware attacks continue to grow in volume and scale, with increased impact to connected medical devices, patient care/safety, and exposure to large global integrated health delivery systems.
By Cathy Thomas Hess – Wound care has undergone a substantial evolution over the past few years, beginning with the introduction of EHRs and continuing today with the incorporation of Artificial Intelligence and Machine Learning.
By Matthew D. Bayley MD – Each year the Medical Group Management Association surveys hundreds of group practices to assess how industry regulations are impacting them. Just as in previous years, the most recent survey shows things are getting worse, not better.
By Ryan Hennen – Lung cancer is the leading cause of cancer deaths worldwide, with approx. 1.8 M each year. Most patients are diagnosed after symptoms have appeared and the disease has progressed to an advanced stage explaing the current worldwide five-year survival rate of just 20%.
By Tom Dorsett – Drug costs are skyrocketing, but why? First we must understand the cause of high drug costs in order to properly address the problem. For more than twenty-five years, I’ve seen drug costs grow and dominate pharmacy budgets across the United States.